Third Circuit Rules on Grounds for a Preliminary Injunction in Pharmaceutical Trademark Case. Law.com reports that the Third Circuit "rejected the novel argument that an injunction was needed to prevent the 'serious health risk' of a patient's receiving the wrong prescription," while nevertheless ordering the district court to grant an injunction to vindicate the "right of the public not to be deceived or confused," in "3rd Circuit Blocks Similar Names for Cholesterol Drugs."